Literature DB >> 7981014

The effects of angiotensin II on circulating levels of natriuretic peptides.

R I Cargill1, W J Coutie, B J Lipworth.   

Abstract

We have evaluated the differential release of A, B and C-type natriuretic peptides in response to incremental doses of angiotensin II (2, 4 and 6 ng kg-1 min-1). Baseline plasma concentrations of ANP (5.99 +/- 0.74 pmol 1-1) were significantly (P < 0.05) higher than BNP (1.53 +/- 0.48 pmol 1-1) or CNP (0.41 +/- 0.11 pmol 1-1). Angiotensin II infusion caused a significant (P < 0.05) increase in plasma ANP to 53.76 +/- 17.3 pmol 1-1 at 6 ng kg-1 min-1. Plasma concentrations of BNP and CNP were not significantly affected by angiotensin II. Arterial blood pressures and systemic vascular resistance increased (P < 0.001) in response to angiotensin II infusion. Thus, ANP, unlike BNP or CNP, is released acutely in response to the pressor stimulus of angiotensin II. This may represent a dissociation in release of the natriuretic peptides, in terms of short and long term responses to activation of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981014      PMCID: PMC1364859          DOI: 10.1111/j.1365-2125.1994.tb04337.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis.

Authors:  C C Lang; A M Choy; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1992-11       Impact factor: 6.124

2.  Effect of vasopressors on atrial natriuretic factor and hemodynamic function in humans.

Authors:  Y Shenker; E R Bates; B H Egan; J Hammoud; R J Grekin
Journal:  Hypertension       Date:  1988-07       Impact factor: 10.190

3.  Effects of angiotensin II and atrial natriuretic peptide alone and in combination on urinary water and electrolyte excretion in man.

Authors:  J McMurray; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1988-04       Impact factor: 6.124

4.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

5.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease.

Authors:  C C Lang; W J Coutie; A D Struthers; D P Dhillon; J H Winter; B J Lipworth
Journal:  Clin Sci (Lond)       Date:  1992-11       Impact factor: 6.124

7.  The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man.

Authors:  C C Lang; A M Choy; K Turner; R Tobin; W Coutie; A D Struthers
Journal:  J Hypertens       Date:  1993-07       Impact factor: 4.844

8.  Natriuretic peptide system in human heart failure.

Authors:  C M Wei; D M Heublein; M A Perrella; A Lerman; R J Rodeheffer; C G McGregor; W D Edwards; H V Schaff; J C Burnett
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

9.  Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; E Morita; N Sakaino; M Jougasaki; M Kurose; M Mukoyama; Y Saito; K Nakao; H Imura
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

10.  Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure.

Authors:  C C Lang; A M Choy; I S Henderson; W J Coutie; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1992-02       Impact factor: 6.124

View more
  7 in total

1.  Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides.

Authors:  Fumiki Yoshihara; Takeshi Tokudome; Ichiro Kishimoto; Kentaro Otani; Atsunori Kuwabara; Takeshi Horio; Yuhei Kawano; Kenji Kangawa
Journal:  Clin Exp Nephrol       Date:  2014-05-21       Impact factor: 2.801

2.  Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans.

Authors:  M C Petrie; J E McDonald; C Hillier; J J Morton; J J McMurray
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

3.  Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans.

Authors:  R I Cargill; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

4.  C-type natriuretic peptide levels in cor pulmonale and in congestive heart failure.

Authors:  R I Cargill; C S Barr; W J Coutie; A D Struthers; B J Lipworth
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

5.  Acute neurohormonal responses to hypoxaemia in man.

Authors:  R I Cargill; L C McFarlane; W J Coutie; B J Lipworth
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

6.  Direct chronotropic effects of atrial and C-type natriuretic peptides in anaesthetized dogs.

Authors:  P Beaulieu; R Cardinal; A De Léan; C Lambert
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Higher serum concentrations of N-terminal pro-B-type natriuretic peptide associate with prevalent hypertension whereas lower associate with incident hypertension.

Authors:  Ekim Seven; Lise L N Husemoen; Hans Ibsen; Nele Friedrich; Matthias Nauck; Kristian Wachtell; Allan Linneberg; Jørgen L Jeppesen
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.